| Related Articles |
Zishenpingchan granules for the treatment of Parkinson’s disease: a randomized, double-blind, placebo-controlled clinical trial.
Neural Regen Res. 2018 Jul;13(7):1269-1275
Authors: Ye Q, Yuan XL, Yuan CX, Zhang HZ, Yang XM
Abstract
Levodopa preparations remain the preferred drug for Parkinson’s disease. However, long-term use of levodopa may lead to a series of motor complications. Previous studies Lees meer
Source:: Pubmed